Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Opioid Use Disorder Market: By Drug: Buprenorphine, Methadone, Naltrexone; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments

Global Opioid Use Disorder Market Outlook

The global opioid use disorder market was valued at USD 1.65 billion in 2020 and is projected to grow at a CAGR of 10% over the forecast period of 2022-2027 owing to the increasing opioid use and the launch of government policies to control the crisis in the U.S.

 

Global Opioid Use Disorder Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Opioid use disorder is a chronic illness combined with compulsive, prolonged, and repeated self-administration of opioids. There are two kinds of patients in opioid use disorder: patients addicted to non-medical opioids and patients addicted to medical opioids. The opioid use disorder market is segmented based on drugs:

 

Global Opioid Use Disorder Market By Drug

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Buprenorphine 
  • Bunavail 
  • Sublocade
  • Suboxone
  • Zubsolv
  • Others
  • Methadone
  • Naltrexone

The EMR report looks into the regional markets of opioid use disorder like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Opioid Use Disorder Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global opioid use disorder market is being driven by the rising cases of opioid addiction. The industry is further driven by factors like the commercialization of a few drugs that are approved for the treatment and genericized across various markets. Buprenorphine-Sublocade is anticipated to be the fastest-growing industry as it directs the restrictions of existing treatment by replacing daily oral medications with an injectable, thus, making diversion and abuse difficult and improving quality of life. North America is the largest market due to the epidemic of opioids in the U.S. and Canada, and the introduction of policies by the government to control the crisis. The U.S. government in January 2018 launched an awareness advertising campaign to resist opioid addiction.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global opioid use disorder market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Indivior PLC
  • BioDelivery Sciences International, Inc.
  • Alkermes, Inc.
  • Titan Pharmaceuticals, Inc.
  • Camurus AB.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug, Region
Breakup by Drug Buprenorphine, Methadone, Naltrexone
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Indivior PLC, BioDelivery Sciences International, Inc., Alkermes plc, Titan Pharmaceuticals, Inc., Camurus AB., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Opioid Use Disorder Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Opioid Use Disorder Historical Market (2017-2021) 
    8.3    Global Opioid Use Disorder Market Forecast (2022-2027)
    8.4    Global Opioid Use Disorder Market by Drug
        8.4.1    Buprenorphine
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.1    Buprenorphine by Type
                8.4.1.1.1    Bunavail
                8.4.1.1.2    Sublocade
                8.4.1.1.3    Suboxone
                8.4.1.1.4    Zubsolv
                8.4.1.1.5    Others
        8.4.2    Methadone
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Naltrexone
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Global Opioid Use Disorder Market by Region
        8.5.1    Market Share
            8.5.1.1    North America
            8.5.1.2    Europe
            8.5.1.3    Asia Pacific
            8.5.1.4    Latin America
            8.5.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Company Profiles
        13.2.1    Indivior PLC 
            13.2.1.1    Company Overview
            13.2.1.2    Product Portfolio
            13.2.1.3    Demographic Reach and Achievements
            13.2.1.4    Certifications
        13.2.2    BioDelivery Sciences International, Inc.
            13.2.2.1    Company Overview
            13.2.2.2    Product Portfolio
            13.2.2.3    Demographic Reach and Achievements
            13.2.2.4    Certifications
        13.2.3     Alkermes plc
            13.2.3.1    Company Overview
            13.2.3.2    Product Portfolio
            13.2.3.3    Demographic Reach and Achievements
            13.2.3.4    Certifications
        13.2.4    Titan Pharmaceuticals, Inc.
            13.2.4.1    Company Overview
            13.2.4.2    Product Portfolio
            13.2.4.3    Demographic Reach and Achievements
            13.2.4.4    Certifications
        13.2.5    Camurus AB.
            13.2.5.1    Company Overview
            13.2.5.2    Product Portfolio
            13.2.5.3    Demographic Reach and Achievements
            13.2.5.4    Certifications
        13.2.6    Others
14    Industry Events and Developments


List of Key Figures and Tables

1.    Global Opioid Use Disorder Market: Key Industry Highlights, 2017 and 2027
2.    Global Opioid Use Disorder Historical Market: Breakup by Drug (USD Million), 2017-2021
3.    Global Opioid Use Disorder Market Forecast: Breakup by Drug (USD Million), 2022-2027
4.    Global Opioid Use Disorder Historical Market: Breakup by Region (USD Million), 2017-2021
5.    Global Opioid Use Disorder Market Forecast: Breakup by Region (USD Million), 2022-2027
6.    North America Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2017-2021
7.    North America Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2022-2027
8.    Europe Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2017-2021
9.    Europe Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Asia Pacific Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Asia Pacific Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Latin America Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Latin America Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Middle East and Africa Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Middle East and Africa Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Global Opioid Use Disorder Market Structure

Key Questions Answered in the Report

The global opioid use disorder market attained a value of USD 1.65 billion in 2020.

In the forecast period 0f 2022-2027, the market is projected to grow at a CAGR of 10%.

The major drivers of the market include commercialisation of a few drugs, introduction of policies by the government, and improving quality of life are expected to aid the industry growth.

Rising cases of opioid addiction and growing dependency on drugs are expected to boost the market growth.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the major regions in the market, with North America accounting for the largest share in the market.

The major drugs of the product are buprenorphine, methadone, and naltrexone. Buprenorphine is further divided into bunavail, sublocade, suboxone, and zubsolv, among others.

The major players in the market are Indivior PLC, BioDelivery Sciences International, Inc., Alkermes plc, Titan Pharmaceuticals, Inc., Camurus AB., Others.

Analyst Review

The global opioid use disorder market attained a value of USD 1.65 billion in 2020 driven by commercialisation of a few drugs that are approved for the treatment and genericized across various markets. Aided by the rising cases of opioid addiction and introduction of policies by the government, the market is expected to further grow at CAGR of 10% in the forecast period of 2022-2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of drugs, the market is divided into buprenorphine, methadone, and naltrexone. Buprenorphine is further divided into bunavail, sublocade, suboxone, and zubsolv, among others. The major regional markets for the product are North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa, with North America accounting for the largest share in the market. The key players in the above industry include Indivior PLC, BioDelivery Sciences International, Inc., Alkermes plc, Titan Pharmaceuticals, Inc., Camurus AB., Others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER